secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2021-12-22T23:59:59+00:00
Accession:  0001437749-21-029110
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne appoints Will Geist President, Protein Sciences Segment, succeeding retiring Dave Eansor
--------------------------------------------------------------------------------

- Geist, former COO of Quanterix and former VP/GM at Thermo Fisher, appointed effective Jan 3, 2022.
- He succeeds N. David Eansor, who will retire and assist transition through Feb 2022.
- Base salary $500,000; target cash bonus 85%; annual equity grants ~$1.8M; one-time RSU grant $1M.
- Geist has over 20 years senior life science tools experience; CEO highlighted his experience running >$1B revenue businesses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/0001437749-21-029110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/tech20211222_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-029110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer